Literature DB >> 19029298

Protein kinase D1 autophosphorylation via distinct mechanisms at Ser744/Ser748 and Ser916.

Vitalyi O Rybin1, Jianfen Guo, Susan F Steinberg.   

Abstract

Protein kinase D1 (PKD1) is a physiologically important signaling enzyme that is activated via protein kinase C-dependent trans-phosphorylation of the activation loop at Ser744 and Ser748 followed by PKD1 autophosphorylation at Ser916. Although PKD-Ser916 autophosphorylation is widely used to track cellular PKD activity, this study exposes conditions leading to increased PKD-Ser(P)916 immunoreactivity without an associated increase in PKD activity in cardiomyocytes that heterologously overexpress catalytically inactive PKD1 and in cardiomyocytes treated with Gö6976 (a PKD inhibitor that competes with ATP). In each case, PKD1 is detected as a Ser916-phosphorylated enzyme that lacks kinase activity. In vitro kinase assays reconcile these seemingly discrepant findings by demonstrating that PKD1-Ser916 autophosphorylation can proceed via either an intermolecular reaction or an intramolecular autophosphorylation that requires only very low ATP concentrations that do not support target substrate phosphorylation. Additional studies show that Ser744 and Ser748 are targets for a protein kinase C-independent autocatalytic phosphorylation and that the PKD1-S744A/S748A mutant is a Ser916-phosphorylated enzyme that is not active toward heterologous substrates. In contrast, PKD1-S916A is an active kinase that autophosphorylates at Ser744. However, the S916A substitution leads to a Ser748 phosphorylation defect and a prolonged cellular PKD1 signaling response. Collectively, these results implicate PKD1-Ser744 phosphorylation in the phorbol 12-myristate 13-acetate-dependent mechanism that increases PKD1 activity toward physiologically relevant substrates. We show that PKD1-Ser916 autophosphorylation does not necessarily correlate with PKD1 activity. Rather, autophosphorylation at Ser916 is required for subsequent autophosphorylation at Ser748. Finally, this study exposes a novel role for Ser916 and/or Ser748 autophosphorylation to terminate the cellular PKD1 signaling response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029298      PMCID: PMC2629118          DOI: 10.1074/jbc.M806381200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Phosphorylation at conserved carboxyl-terminal hydrophobic motif regulates the catalytic and regulatory domains of protein kinase C.

Authors:  A S Edwards; A C Newton
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

2.  Mechanism of persistent protein kinase D1 translocation and activation.

Authors:  Elena Oancea; Vassilios J Bezzerides; Anna Greka; David E Clapham
Journal:  Dev Cell       Date:  2003-04       Impact factor: 12.270

3.  Oxidative stress induces protein kinase C-mediated activation loop phosphorylation and nuclear redistribution of protein kinase D.

Authors:  Richard T Waldron; Osvaldo Rey; Elena Zhukova; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2004-04-14       Impact factor: 5.157

4.  Stimulus-specific differences in protein kinase C delta localization and activation mechanisms in cardiomyocytes.

Authors:  Vitalyi O Rybin; Jianfen Guo; Abdelkarim Sabri; Hasnae Elouardighi; Erik Schaefer; Susan F Steinberg
Journal:  J Biol Chem       Date:  2004-02-17       Impact factor: 5.157

5.  Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor kappaB.

Authors:  Peter Storz; Heike Döppler; Alex Toker
Journal:  Mol Pharmacol       Date:  2004-06-29       Impact factor: 4.436

6.  Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase.

Authors:  D R Knighton; J H Zheng; L F Ten Eyck; V A Ashford; N H Xuong; S S Taylor; J M Sowadski
Journal:  Science       Date:  1991-07-26       Impact factor: 47.728

7.  Protein kinase D links Gq-coupled receptors to cAMP response element-binding protein (CREB)-Ser133 phosphorylation in the heart.

Authors:  Nazira Ozgen; Maria Obreztchikova; Jianfen Guo; Hasnae Elouardighi; Gerald W Dorn; Brenda A Wilson; Susan F Steinberg
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

8.  Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5.

Authors:  Rick B Vega; Brooke C Harrison; Eric Meadows; Charles R Roberts; Philip J Papst; Eric N Olson; Timothy A McKinsey
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

9.  Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling.

Authors:  Peter Storz; Heike Döppler; Alex Toker
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Structural requirements for localization and activation of protein kinase C mu (PKC mu) at the Golgi compartment.

Authors:  Angelika Hausser; Gisela Link; Linda Bamberg; Annett Burzlaff; Sylke Lutz; Klaus Pfizenmaier; Franz-Josef Johannes
Journal:  J Cell Biol       Date:  2002-01-03       Impact factor: 10.539

View more
  32 in total

1.  M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1.

Authors:  Kok Choi Kong; Adrian J Butcher; Phillip McWilliams; David Jones; Jürgen Wess; Fadi F Hamdan; Tim Werry; Elizabeth M Rosethorne; Steven J Charlton; Sarah E Munson; Hannah A Cragg; Alison D Smart; Andrew B Tobin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

2.  Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein.

Authors:  Yutaka Amako; Gulam H Syed; Aleem Siddiqui
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

3.  Novel function of cardiac protein kinase D1 as a dynamic regulator of Ca2+ sensitivity of contraction.

Authors:  Mariah H Goodall; Robert D Wardlow; Rebecca R Goldblum; Andrew Ziman; W Jonathan Lederer; William Randall; Terry B Rogers
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

4.  Promiscuous actions of small molecule inhibitors of the protein kinase D-class IIa HDAC axis in striated muscle.

Authors:  Douglas D Lemon; Brooke C Harrison; Todd R Horn; Matthew S Stratton; Bradley S Ferguson; Michael F Wempe; Timothy A McKinsey
Journal:  FEBS Lett       Date:  2015-03-25       Impact factor: 4.124

Review 5.  Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology.

Authors:  Ya Fu; Charles S Rubin
Journal:  EMBO Rep       Date:  2011-07-08       Impact factor: 8.807

6.  Protein kinase Cδ mediates the activation of protein kinase D2 in platelets.

Authors:  Dheeraj Bhavanasi; Soochong Kim; Lawrence E Goldfinger; Satya P Kunapuli
Journal:  Biochem Pharmacol       Date:  2011-06-28       Impact factor: 5.858

7.  PKD3 deficiency causes alterations in microtubule dynamics during the cell cycle.

Authors:  Tianzhou Zhang; Ursula Braun; Michael Leitges
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

8.  Overcoming amino-Nogo-induced inhibition of cell spreading and neurite outgrowth by 12-O-tetradecanoylphorbol-13-acetate-type tumor promoters.

Authors:  Kangwen Deng; Ying Gao; Zixuan Cao; Edmund I Graziani; Andrew Wood; Patrick Doherty; Frank S Walsh
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

9.  Characterization of the biological effects of a novel protein kinase D inhibitor in endothelial cells.

Authors:  Ian M Evans; Azadeh Bagherzadeh; Mark Charles; Tony Raynham; Chris Ireson; Alexandra Boakes; Lloyd Kelland; Ian C Zachary
Journal:  Biochem J       Date:  2010-08-01       Impact factor: 3.857

10.  Reactive oxygen species decrease cAMP response element binding protein expression in cardiomyocytes via a protein kinase D1-dependent mechanism that does not require Ser133 phosphorylation.

Authors:  Nazira Ozgen; Jianfen Guo; Zoya Gertsberg; Peter Danilo; Michael R Rosen; Susan F Steinberg
Journal:  Mol Pharmacol       Date:  2009-07-20       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.